文献速递中毒与环境急症消化、代谢与肾脏急症

不列颠哥伦比亚省更安全阿片类药物供应政策与阿片类药物结局

British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
PubMed 文献 · JAMA Intern Med · 2024-01-01
一句话结论不列颠哥伦比亚省更安全阿片类药物供应政策与阿片类药物处方率升高相关,但也与阿片类药物相关中毒住院率显著增加相关,阿片类药物毒性死亡无显著变化。

该队列研究使用2016年第一季度至2022年第一季度省水平季度数据,比较实施更安全阿片类药物供应政策的不列颠哥伦比亚省与未实施的曼尼托巴省和萨斯喀彻温省。双重差分分析显示,政策实施与阿片类药物处方率(每10万人2619.6,95%CI 1322.1-3917.0,P<.001)和索赔者率(每10万人176.4,95%CI 33.5-319.4,P=.02)显著增加相关,开处方者率无显著变化(每10万人15.7,95%CI -0.2至31.6,P=.053)。阿片类药物相关中毒住院率增加每10万人3.2(95%CI 0.9-5.6,P=.01),明显阿片类药物毒性死亡无统计学显著变化(每10万人1.6,95%CI -1.3至4.5,P=.26)。作者认为这些发现有助于为正在讨论该政策的司法管辖区提供信息。

要点

  • 政策实施与阿片类药物处方率增加每10万人2619.6(95%CI 1322.1-3917.0,P<.001)和索赔者率增加每10万人176.4(95%CI 33.5-319.4,P=.02)相关。
  • 开处方者率变化无统计学显著差异(每10万人15.7,95%CI -0.2至31.6,P=.053)。
  • 政策实施后阿片类药物相关中毒住院率增加每10万人3.2(95%CI 0.9-5.6,P=.01)。
  • 明显阿片类药物毒性死亡无统计学显著变化(每10万人1.6,95%CI -1.3至4.5,P=.26)。

适用人群与场景

  • 不列颠哥伦比亚省、曼尼托巴省和萨斯喀彻温省的省级季度数据,2016年第一季度(2016年1月1日)至2022年第一季度(2022年3月31日)。
  • 政策允许高过量或中毒风险阿片类药物使用障碍个体接受医生或执业护士开具的药用级阿片类药物。

研究设计与关键结果

  • 研究类型:队列研究,使用2016年第一季度至2022年第一季度不列颠哥伦比亚省(实施政策)与曼尼托巴省和萨斯喀彻温省(未实施政策)的省级季度数据。
  • 暴露:不列颠哥伦比亚省于2020年3月实施的更安全阿片类药物供应政策。
  • 主要结局:政策针对的阿片类药物(氢吗啡酮、吗啡、羟考酮和芬太尼)的处方率、索赔者率和开处方者率;阿片类药物相关中毒住院;明显阿片类药物毒性死亡。
  • 结果:政策与阿片类药物处方率增加每10万人2619.6(95%CI 1322.1-3917.0,P<.001)和索赔者率增加每10万人176.4(95%CI 33.5-319.4,P=.02)相关。
  • 结果:开处方者率变化无统计学显著差异(每10万人15.7,95%CI -0.2至31.6,P=.053)。
  • 结果:阿片类药物相关中毒住院率增加每10万人3.2(95%CI 0.9-5.6,P=.01)。
  • 结果:明显阿片类药物毒性死亡无统计学显著变化(每10万人1.6,95%CI -1.3至4.5,P=.26)。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些发现将有助于为不列颠哥伦比亚省及其他正在考虑该政策的司法管辖区关于该政策的持续讨论提供信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: In March 2020, British Columbia, Canada, became the first jurisdiction globally to launch a large-scale provincewide safer supply policy. The policy allowed individuals with opioid use disorder at high risk of overdose or poisoning to receive pharmaceutical-grade opioids prescribed by a physician or nurse practitioner, but to date, opioid-related outcomes after policy implementation have not been explored.

OBJECTIVE: To investigate the association of British Columbia's Safer Opioid Supply policy with opioid prescribing and opioid-related health outcomes.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study used quarterly province-level data from quarter 1 of 2016 (January 1, 2016) to quarter 1 of 2022 (March 31, 2022), from British Columbia, where the Safer Opioid Supply policy was implemented, and Manitoba and Saskatchewan, where the policy was not implemented (comparison provinces).

EXPOSURE: Safer Opioid Supply policy implemented in British Columbia in March 2020.

MAIN OUTCOMES AND MEASURES: The main outcomes were rates of prescriptions, claimants, and prescribers of opioids targeted by the Safer Opioid Supply policy (hydromorphone, morphine, oxycodone, and fentanyl); opioid-related poisoning hospitalizations; and deaths from apparent opioid toxicity. Difference-in-differences analysis was used to compare changes in outcomes before and after policy implementation in British Columbia with those in the comparison provinces.

RESULTS: The Safer Opioid Supply policy was associated with statistically significant increases in rates of opioid prescriptions (2619.6 per 100 000 population; 95% CI, 1322.1-3917.0 per 100 000 population; P < .001) and claimants (176.4 per 100 000 population; 95% CI, 33.5-319.4 per 100 000 population; P = .02). There was no significant change in prescribers (15.7 per 100 000 population; 95% CI, -0.2 to 31.6 per 100 000 population; P = .053). However, the opioid-related poisoning hospitalization rate increased by 3.2 per 100 000 population (95% CI, 0.9-5.6 per 100 000 population; P = .01) after policy implementation. There were no statistically significant changes in deaths from apparent opioid toxicity (1.6 per 100 000 population; 95% CI, -1.3 to 4.5 per 100 000 population; P = .26).

CONCLUSIONS AND RELEVANCE: Two years after its launch, the Safer Opioid Supply policy in British Columbia was associated with higher rates of safer supply opioid prescribing but also with a significant increase in opioid-related poisoning hospitalizations. These findings will help inform ongoing debates about this policy not only in British Columbia but also in other jurisdictions that are contemplating it.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Nguyen HV, Mital S, Bugden S, et al. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes. JAMA Intern Med. 2024. PMID: 38227344. doi:10.1001/jamainternmed.2023.7570

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。